Key result
Doxorubicin drives cardiac fibroblast senescence, increasing SA-β-Gal-positive cells by ~10 percentage points.
Why the study?
Cardiac fibroblast senescence and the senescence-associated secretory phenotype are implicated in anthracycline-induced cardiotoxicity, but the early secretory responses preceding established senescence after doxorubicin exposure remain poorly defined.
Does acute doxorubicin exposure alter the early secretome, viability, proliferation, and senescence-associated β-galactosidase activity in primary rat cardiac fibroblasts?
Does acute doxorubicin exposure alter the early secretome, viability, proliferation, and senescence-associated β-galactosidase activity in primary rat cardiac fibroblasts?
Acute doxorubicin exposure in cardiac fibroblasts induces early proliferative arrest and secretome remodeling—characterized by suppressed extracellular matrix proteins and increased mitochondrial stress proteins—prior to the emergence of overt cellular senescence at Day 7.
Answers are grounded in this paper and cite their sources.
Early secretome remodeling precedes fibroblast senescence after doxorubicin; hypothesis-generating in animal models and warrants human studies before clinical relevance.
Anthracycline-induced cardiotoxicity is associated with progressive cardiac dysfunction and fibrotic remodeling, processes in which cardiac fibroblast senescence and the senescence-associated secretory phenotype have been implicated. However, the early secretory responses that precede established senescence following doxorubicin (DOX) exposure remain poorly defined. Primary cardiac fibroblasts isolated from healthy rat hearts were treated with varying concentrations of DOX (0-3 μM) for 24 hours. Media collected at Day 1 were analyzed by untargeted proteomics, while cell viability, proliferation, and senescence-associated β-galactosidase activity were assessed at Days 1 and 7. Acute DOX exposure reduced cell viability and proliferation at Day 1 without significantly increasing senescence-associated β-galactosidase activity. At Day 7, we observed persistent proliferative arrest and increased β-galactosidase activity with DOX exposure, consistent with delayed senescence. Proteomic analysis of Day 1 conditioned media identified 35 proteins significantly associated with DOX treatment after false discovery rate correction (22 positive and 13 negative associations; P-FDR < 0.05). Functional annotation identified proteins related to extracellular matrix (ECM) regulation, mitochondrial function, cellular stress, cytoskeletal organization, calcium signaling, protease activity, and cell-cycle regulation. Network analysis identified a collagen-centered network (COL1A1, COL1A2, and COL3A1) associated with reduced abundance of ECM proteins and a second network centered on GAPDH, HSPA8, and HSPA9 that included proteins associated with mitochondrial proteostasis, oxidative stress, metabolic adaptation, and structural remodeling.
No takes yet. Share an insight, caveat, or question.
Riojas et al. (2026) studied Anthracycline-induced cardiotoxicity / cardiac fibroblast senescence (n=4). Doxorubicin (DOX) vs. Untreated control (0 μM DOX) was evaluated on Early secretory proteomic profile (Day 1 conditioned media proteins significantly associated with DOX concentration) and senescence-associated β-galactosidase (SA-β-Gal) activity at Day 7 (p=0.0323). Doxorubicin altered 35 secreted proteins at Day 1 and increased senescent SA-β-Gal-positive cardiac fibroblasts at Day 7.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: